Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Tables)

v3.10.0.1
Basis of Presentation and Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company had the following anti-dilutive common stock equivalents as calculated under the treasury stock method:

 

    For the Three Months Ended June 30,     For the Six Months Ended June 30,  
    2018     2017     2018     2017  
Convertible preferred stock, Series A(a)     28,324       26,687       28,324       26,687  
Convertible preferred stock, Series A-1(a)     17,937       15,746       17,937       15,746  
Common stock warrants     1,122,520       819,925       1,122,520       819,925  
Restricted stock units     322,921       322,921       322,921       322,921  
Options     46,634             46,634        
Total potentially dilutive shares     1,538,336       1,185,279       1,538,336       1,185,279  

 

  (a) Dilutive effect of convertible securities are included in diluted EPS by application of the if-converted method.